BioTuesdays

Category - Features

BriaCell breast cancer program ready for partnering

Dr. Bill Williams, President and CEO BriaCell Therapeutics (OTCQB:BCTXD; TSXV:BCT) believes its Phase 2 clinical program in advanced breast cancer, which includes an ongoing combination study of its Bria-IMT with immune...

Subscribe

Sign up to our weekly BioTuesdays newsletter.